Search results for "Nabota"

Daewoong Pharmaceutical’s Nabota Enters Kuwait, Expanding Middle East Footprint to Seven Countries

Daewoong Pharmaceutical’s Nabota Enters Kuwait, Expanding Middle East Footprint to Seven Countries

Daewoong Pharmaceutical’s botulinum toxin product Nabota has entered Kuwait, expanding its Middle East footprint to seven countries.
Daewoong Pharmaceutical Cuts Off Hospital Sales After Domestic Nabota Vials Surface in the U.S.

Daewoong Pharmaceutical Cuts Off Hospital Sales After Domestic Nabota Vials Surface in the U.S.

Daewoong Pharmaceutical announced on July 23 that it has severed supply transactions with a domestic medical institution after discovering two vials...
Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch

Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch

Daewoong Pharmaceutical announced on the 13th that its flagship botulinum toxin product, Nabota, surpassed 1 trillion...
Daewoong Pharmaceutical: Record

Daewoong Pharmaceutical: Record "Nabota" Sales Clouded by Looming Legal Risks

As Daewoong Pharmaceutical celebrates record-breaking financial results driven by its flagship botulinum toxin, Nabota,...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2

Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2

South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?

K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?

Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first,...